-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Alternative Dosing and Prevention of Transfusions (ADAPT): A Prospective Trial to Quantify the Change in Blood Transfusion Use with Hydroxyurea Treatment and the Feasibility of Pharmacokinetic-Guided Dosing in Children with Sickle Cell Anemia in Uganda

Program: Special-Interest Sessions
Session: Hematology Inclusion Pathway (HIP) Oral Presentations - Health Services Outcomes
Saturday, December 7, 2024, 6:00 PM-9:00 PM

Alexandra Power-Hays, MD

Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

Disclosures: Power-Hays: Novo Nordisk: Other: Health Equity Advisory Board.

See more of: Hematology Inclusion Pathway (HIP) Oral Presentations - Health Services Outcomes
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation